The following pain management
protocol of Stuart L. Weg, M.D. is presented as an adjunct therapy to the
antibiotic protocol for inflammatory rheumatic diseases presented on this
web page, particularly for patients with intractable pain.
Dr. Weg is an anesthesiologist specializing in pain management. He practices
at several locations in New York - West End Avenue and Grand Central in Manhattan,
as well as in Mt. Kisco, NY (Westchester), Suffern, NY, Latham, NY (near Albany)
and also in Broomfield, NJ. He can be reached through his secretary at 1-201-320-6758.
He is a member of the following organizations:
Diplomat American Board of Anesthesiology with added Qualification
in Pain Management
Fellow American College of Anesthesiologists
Diplomat American Academy of Pain Management
Member American Board of Oxidative Medicine
ANTI-INFECTIVE PAIN MANAGEMENT PROTOCOL
Part One - Patient home therapeutics
Home oxidative therapy with hydrogen peroxide for all patients:
A. Peroxide baths: Mix 3-4, 16 oz. common brown bottles of 3% peroxide
in a hot water bath with 2 cups of Epsom salt. Soak for 30 minutes. Do
this at least 1 to 3 times per week (no vitamins should be taken 4-8 hours
before bath). This is the preferred way to take peroxide. Still better
is a Jacuzzi with the jets turned on. This enhances the effects. A home
whirlpool such as Polinex (cost about $110) fits on a standard bathtub
and also greatly improves the effect. Increase the amount of peroxide and
Epsom salt proportionally for the larger tub sizes. For economic bulk purchase
of peroxide, consider obtaining the concentrated 27% solution sold by the
gallon as a cleaner in some swimming pool shops. It is called "Baqua Shock".
This product is dangerous to the skin right out of the bottle. It must
be diluted in your bath. Use about 1/10 the volume needed of 3% peroxide
in your baths.
B. Peroxide sponge/spray bath: Apply straight or dilute 3% peroxide,
less than a full 16 oz. bottle in total, to your skin. Use liberally directly
over as much surface as you can. Leave this on for up to 5 minutes and
then wash off. This technique can work very well especially after a work
out, hot shower or hot tub, when you are warm and/or sweaty with your pores
open. To obtain results equivalent to a bath, it is required that you first
apply the tanning product described below and wait about 5 minutes for
your skin to flush before applying the peroxide.
HIGHLY RECOMMENDED - The use of Swedish Beauty "type A" or "Platinum"
tingle factor 2 or 3 brand of tanning accelerator (available at tanning
salons) applied to your skin and left on for 5 minutes before you sponge
or bathe greatly increases the absorption of peroxide. The phone number
of the manufacturer of this product is 1-800-532-9035. Note: The tanning
accelerator should make you red and flushed before you apply peroxide to
the skin. Try it on a small area first and then increase with each bath/sponge
as tolerated.
Other home oxidation techniques
C. Oral Peroxide: Use 3% without preservatives. Take one capful in
a full glass of water daily as tolerated, on empty stomach. (Substitute
35% food grade drops if possible). This is recommended only in cases when
baths or IV's are not available. CAUTION: Although approved by the FDA
as a food additive, some doctors believe oral H2O2 can be dangerous.
D. Peroxide mouth irrigation: Use 1 part 3% peroxide with 2-5 parts
warm water three times a day. Vigorously swish this mixture around in your
mouth for 5 minutes rinsing several times. (Use 3 times daily for acute
migraines or other head, neck or dental problems - especially recommended
for sinusitis.) Using a Waterpik device for this treatment greatly enhances
its effectiveness.
E. Peroxide enema: 1-4 tablespoons in 1 liter instilled rectally
(works well in CFIDS)
F. Ozone baths in hot tubs etc. with ozone sterilized water may not
contain enough ozone to have much therapeutic effect. If adequate ozone
levels are achieved, the effect is excellent.
G. The exposure of the skin to the sun or tanning salon without UV
blockers will cause a systemic oxidizing effect by the UV rays reaching
the blood near the surface. The use of the Swedish Beauty tanning accelerator
greatly enhances the effect. High levels of oral vitamin C help avoid skin
damage, but gradual, controlled exposure is important to avoid injury.
Note: You should have vitamin C out of your system (at least 4 hours)
before getting peroxide in any form. It's not dangerous if you forget.
It just makes the peroxide treatment less effective. Vitamins should be
resumed immediately after the peroxide.
H. Immersion baths with sodium bicarbonate (baking soda) or lathering
up to the neck with alkaline bar soap (Fels Naptha laundry soap) will help
with achy flare reactions that can occur after oxidative therapies.
Essential Nutrients for all patients
1. Vitamin C . Push to bowel tolerance. This means take 500 mg to
3000 mg (1/2 to 3 grams) at a time and throughout the day until you get
diarrhea, gas etc. then back down to what you can handle. Keep that dose
daily and increase in times of flare to as much as 20,000 mg (20 grams)
daily. Tablets are for daily use and one teaspoon of powder for flare problems.
One level teaspoon of ascorbic acid powder equals 5 grams of Vitamin C.
A typical dose is around 2-8 grams daily.
2. Acidophilus with Bifidus, taken daily. This should be taken in
doses of 2-3 times recommended on package. Buy several brands and dissolve
some in bottled chlorine free water before ingesting. If you have rectal
mucus you should consider taking enemas of this supplement. This is the
simplest and safest way to enhance colon health.
3. Mixed fiber daily 30 grams or more. This may be adjusted for people
who consume lots of fruit, vegetables etc. Both soluble (oat, psyllium,
flax) and insoluble (wheat, rice) bran must be included. Omit wheat bran
if you are on a wheat free diet. This is needed for two reasons: First
to avoid constipation associated with narcotics and second to promote colon
health by reducing stagnation and overgrowth leading to high levels of
bacterial translocation.
4. Grape Seed extract (also known as pycnogenol) 100 mg daily. This
is an anti-fungal and anti-microbial, especially in the bowel.
Less essential nutritional supplements
5. Milk Thistle daily as directed on the bottle. (This herb is very
important if you take medication.)
6. Coenzyme Q10 - 100-300mg daily. (This supplement is very important
in heart patients.)
7. Flax seed oil - use on food daily
8. Vitamin E 1200 I.U. daily
9. Good high potency multiple vitamin with trace minerals daily
10. Bioflavinoids (usually contained in vitamin C preparations)
11. Selenium +/- 100 mcg daily
12. Calcium 1000 mg with magnesium 500 mg daily
13. Borage oil is available in capsules. Take 1000 mg daily.
Very useful supplements in selected patients and conditions:
14. Cranberry concentrate tablets are very effective with uncomplicated
urinary symptoms, enhancing secretion of shed urinary bacteria. Use only
as needed.
15. Bismuth 120-240 mg tablets (available as Formula SF734 by Thorne
Research) are reported by many patients to be highly effective for gastric
discomfort. This is a mandatory replacement for H (stomach acid) blockers
that are specifically avoided on this protocol. Use only as needed.
16. Undecyn 150 mg. 1-5 tablespoons orally 2-3 times daily. This
is an anti-fungal for people intolerant of Nystatin or wanting to use an
over the counter product etc. Pharmacies and physicians can order this
from Thorne Research, Product #SF742, 1-800-228-1966.
17. Glucosamine sulfate & chondroitin sulfate (separate or combined
pills). Many people are now reporting that this is effective for joint
and general pains. Take the recommended dosage on the bottle.
18. N-acetyl-cycteine or NAC is specifically recommended for assistance
in drainage of sinus infections. Use only when needed.
The following are promising and under investigation. They are optional
due to limited physician experience.
19. Catsclaw 1,000-3,000 mg/daily. Take this intermittently. The
tea seems to work better than the pills. Find a brand that is best for
you.
20. Wheat, milk and sugar free diet. These foods may be reintroduced
after one month, one at a time
21. L glutamine for digestive/gut problems
22. Cartilage products (shark, beef, chicken). Hylauronic acid (in
the cartilage) is a potent anti-infective substance.
23. MSM taken in dosages of about 1500 mg per day is useful for muscle
aches.
Very important things NOT to do
Patients must cease using tobacco products completely and greatly
limit alcohol if they expect any of these therapies to be successful!
NO cortisone, prednisone or any other corticosteroids should EVER
be used. This includes nasal or lung sprays and any skin products whether
over the counter or by prescription.
Patients must also try to avoid all nonsteroidal medications including
aspirin and Tylenol as well as all of the other over the counter pain remedies
such as Motrin, Aleve, Excedrin, etc. These medications will make the pain
and disease worse over the long run. Pure narcotic analgesics can be used
as needed without this danger.
Part Two - Medications and treatments that can only be
given under a physician's supervision
Oral antibiotic medications:
1a. Low dose or Dr. Brown Protocol: Minocycline/doxycycline 50-200
mgs M-W-F for extended periods
1b. High dose or Dr. Nicholson (Gulf War Illness) Protocol: Doxycycline
200- 300mg/day for 6 week cycles. (May also substitute/rotate Biaxin, Cipro,
Zithromax, and minocycline.)
Editor's note: We have discovered ALL minocycline is not therapeutically
equivalent. The only generic proven to work consistently is the one by
Wyeth Ayerst (Lederle). We discovered this problem back in 1997, and a
number of people in the support group reported they had 'lost' up to 2-1/2
years on this therapy because of being on an ineffective generic.
2. Sporanox for visible foot or skin fungus, 200 mg daily one week
per month or one day per week rotations. Diflucan is being used in some
patients.
3. Nystatin tablets for suspected GI candida 1-3 million units/day.
(Typically patients alternate 1 week of Sporanox with 3 weeks of Nystatin)
The liquid is preferred over the tablets.
4. Nystatin Liquid is sometimes necessary for stomach or nausea problems.
(It may be used with Bismuth). It is formulated as 100,000 units per ml.
Take a tablespoon (15ml) several times a day instead of the tablets. Rinse
your mouth after use, but try to avoid swallowing anything for at least
15 minutes to get prolonged coverage of the stomach and esophagus with
the drug.
Home daily IM injection therapy:
These assist in selected cases such as MS or CFIDS or where pain
is associated with fatigue.
1. Kutapressin 2 ml. IM QD
2. B12 1000 units/ml injections 1cc IM. QD. (This can be given in
the same syringe as Kutapressin)
Office treatments
Oxidative therapies:
1. Photoxidation of blood with ultraviolet light - UBI Technique
(Knott) with added H2O2, O2 and or ozone up to 0.5 to 5% of total blood
volume per treatment.
2. IV H2O2 Infusion - Farr formula (.03 - .10% H2O2 in 250 ml D5W
with magnesium and manganese)
3. IV high dose Vitamin C 10-50 grams with added vitamins and magnesium
in 250-500 ml of sterile water.
4. Chelation therapy with IV EDTA
5. Ozone therapy, bag technique, rectal insufflation, Hemoautotherapy.
6. Injection technique for painful areas mixing ozone gas and/or
peroxide with 1/2 - 1% lidocaine then infiltrating.
7. High dosage (8-25,000 units of hydrocobalamin IV) B12 infusions
are very effective for neuropathies in MS, Lyme, DM etc., given with Ascorbate
in sterile water or D5W.
Antibiotic therapies:
8. IV doxycycline 100-200 mg.
9. IV or IM clindamycin 300-1200 mg.
10. Injections of painful areas: Preservative free freshly mixed
1/2% lidocaine with 1 to 400,000 epinephrine plus 0.2 ml 3% peroxide per
10ml of local. Then a second pass - optional (after 15-30 minutes) - 150-600
mg of clindamycin per 10ml of sterile water - selected cases only.
HYDROGEN PEROXIDE PROTOCOL REFERENCES
-
1. Oliver TH, Cantab BC, and Murphy DV: Influenzal Intravenous Injection
of Hydrogen Peroxide. Lancet 1920; 1:432-433
-
2. Ramasarma T: Generation of H202 in Biomembranes. Biochemica et
Biophysica ACTA 1982; 694: 69-93
-
3. Garner MH, Garner WH, Spector A: Kinetic Cooperativity Change
after H202 Modification of (Na,K)- ATPase. J Biolog Chem 1984; 259: 7712-7718
-
4. Wildberger E, Kohler H, Jenzer H, et al: Inactivation of Peroxidase
and Glucose Oxidase by H202 and Iodide during In Vitro Thyroglobulin lodination.
Mol Cell Endocrinol 1986; 46(2):149-154
-
5. Swaroop A and Ramasarma T: Heat Exposure and Hypothyroid Conditions
Decrease Hydrogen Peroxide Production Generation in Liver Mitochrondia.
J Biochem 1985; 226(2): 403-8
-
6. Nelson DH and Murray DK: Dexamethasone Inhibition of Hydrogen
Peroxide- stimulated Glucose Transport. Endocrinology 1987; 120(l): 156-159
-
7. by the Decomposition of Hydrogen Peroxide. Texas Rpts Biol and
Med 1964; 22: 106-109
-
8. Balla GA, Finney JW, Aronoff BL, et al: Use of Intra-arterial
Hydrogen Peroxide to Promote Wound Healing. Am J Surg 1964; 108: 621-629
-
9. Zoschke DC and Staite ND: Suppression of Human Lymphocyte Proliforation
by Activated Neutrophils or H202: Surviving Cells have an Altered T Helper/,r
Suppressor Ratio and an Increased Resistance to Secondary Oxidant Exposure.
Clin Immunol Immunopathol 1987; 42(2): 160-70
-
10. Finney JW, Balla GA, Race GJ, et al: Peripheral Blood Changes
in Humans and Experimental Animals Following the Infusion of Hydrogen Peroxide
into the Carotid Artery. Angio 1965; 16: 62-66
-
11. Mallams JT, Finney JW, and Balla GA: The Use of Hydrogen Peroxide
As A Source of Oxygen in A Regional Intra-Arterial Infusion System. So
M J 1962; 55: 230-232
-
12. Fuson RI, Kylstra JA, Hochstein P, et al: Intravenous Hydrogen
Peroxide Infusion as a Means of Extrapulmonary Oxygenation. Clin Res 1967;
15: 74
-
13. Minotti G and Aust SD: The Requirement for Iron(III) in the Initiation
of Lipid Peroxidation by Iron(II) and Hydrogen Peroxide. J Biol Chem 1987:
262(3): 1098-104
-
14. Farr CH: The Therapeutic Use of Intravenous Hydrogen Peroxide
(Monograph). Genesis Medical Center, Oklahoma City, OK 73139, Jan. 1987
-
15. Finney JW, Jay BE, Race GJ, et al: Removal of Cholesterol and
Other Lipids from Experimental Animal and Human Atheromatous Arteries by
Dilute Hydrogen Peroxide. Angiology 1966; 17: 223-228
-
16. Weiss SJ, Young J, LoBuglio A, et al: Role of Hydrogen Peroxide
in Neutrophil- Mediated Destruction of Cultured Endothelial Cells. J. Clin
Invest 1981; 68: 714-721
-
17. Urschel HE Jr: Cardiovascular Effects of Hydrogen Peroxide: Current
Status. Dis of Chest 1967; 51: 180- 192
-
18. Finney JW, Urschel HC, Balla GA, et al: Protection of the Ischemic
Heart with DMSO Alone or DMSO with Hydrogen Peroxide. Ann NY Acad Sci 1967;
151: 231- 241
-
19. Urschel HC, Finney JW, Morale AR, et al: Cardiac Resuscitation
with Hydrogen Peroxide. Circ 1965; 31 (suppi 11): 11-210
-
20. Ackerman NB, Brinkley FB: Comparison of Effects on Tissue Oxygenation
of Hyperbaric Oxygen and Intravascular Hydrogen Peroxide. Sur 1968; 63:
285-290
-
21. Germon PA, Faust DS, Brady, LW: Comparison of Arterial and Tissue
Oxygen Measurements in Humans Receiving Regional Hydrogen Peroxide Infusions
and Oxygen Inhalation. Radiology 1968; 91:669-672
-
22. Lorinez AL, Jacoby JJ, Livingstone MM: Studies on the Parenteral
Administration of Hydrogen Peroxide. Anesthesiology 1948; 9: 162-174
-
23. Hothersall JD, Greenbaum AL, McLean P: The Functional Significance
of the Pentose Phosphate Pathway in Synaptosomes: Protection Against PeroAdative
Damage by Catecholamines and OAdants. J Neurochem 1982; 39: 1325-1332
-
24. Del Maestro RF, Thaw HH, Bjork J et al: Free Radicals as Mediators
of Tissue injury. Acta Physiol Scand 1980; 492(suppi): 43-57
-
25. Yamaja Setty BN, Jurck E, Ganley C et al: Effects of Hydrogen
Peroxide on Vascular Arachidonic Acid Metabolism. Prostag Leuko Med 1984;
14: 205-213
-
26. Polgar P, Taylor L: Stimulation of Prostaglandin Synthesis by
Ascorbic Acid via Hydrogen Pcroxide Formation. Prostag 1980; 19: 693
-
27. Marshall PJ and Lands : In Vitro Formation of Activators for
Prostaglandin Synthesis by Neutrophils and Macrophages from Humans and
Guinea Pigs. J Lab Clin Med 1986; 108(6): 525-534
-
28. Tappel AL: Lipid Peroxidation Damage to Cell Component. Fed Proc
1973; 32: 1870
-
29. Shimada 0 and Yashuda H: Lipid Peroxidation and its Inhibition
by Tinoridine. Biochem Biophys ACTA 1979; 572:531
-
30. Morehouse LA, Tien M, Bucher JR et al: Effect of Hydrogen Peroxide
on the Initiation of Microsomal Lipid Pero)ddation. Biochem Pharm 1983;
32: 123-127
-
31. Dockrell HM and Playfair JH: Killing of Blood-Stage Murine Malaria
Parasites by Hydrogen Peroxide. Infect Immun 1983;39: 456-459
-
32. Root R& Metcalf J, Oshino N, et al: H202 Release from Human
Granulocytes during Phagocytosis. J Clin Invest 1975; 55: 945-955
-
33. Root RK and Metcalf JA: H202 Release from Human Granulocytes
during Phagocytosis. J Clin Invest 1977; 60: 1266-1279
-
34. Harrison JF and Schultz J: Studies on the Chlorinating Activity
of Myeloperoxidase. J Biol Chem 1976; 251:1371-1374
-
35. Zgiiczynski JM, Selvaraj RJ, Paul BB, et al: Chlorination by
the MyelopcroAdase- H202-Cl antimicrobial system at Acid and Neutral pH.
Proc Soc Exp Biol Med 1977; 154:418-422
-
36. Klebanoff SJ: Oxygen Metabolism and the toxic Properties of Phagocytcs.
Ann Intern Med 1980;93:480- 489
-
37. Slivka A, LoBuglio AF, Weiss SJ: A Potential Role for Hypochlorous
Acid in Granulocyte- Mediated Tumor Cell Cytotoxicity. Blood 1980; 55:
347-350
-
38. Thomas EL: Mycloperoxidase, Hydrogen Peroxide, Chloride Antimicrobial
System: Nitrogen-Clorine Derivatives of Bacteria [Components in Bacteria]
Action against Eschericia coli. Infec Immun 1979; 23: 522-531
-
39. Nathan CF and Cohn ZA: Antitumor Effects of Hydrogen Peroxide
in Vivo. J Exp Med 1981; 154:1539- 1553
-
40. Munakata T, Semba U, Shibuya Y et al: Induction of Interferon-gamma
Production by Human Natural Killer Cells Stimulated by Hydrogen Peroxide.
J Immunol 1985; 134(4): 2449-2455
-
41. Lebcdev LV, Levin AO, Romank-ova MP, et al: Regional Oxygenation
in the Treatment of Severe Destructive Forms of Obliterating Diseases of
the Extremity Arteries. Vestn Khir 1984; 132: 85-88
-
42. Gusak V& Klioner LI, Belinski VE et al: Possibilities of
Using Weak Solutions of Hydrogen Peroxide in the Treatment of Experimental
Ischemia of the Lower Extremities. YJin Khir 1986;7: 31-33
-
43. Jepras RI and Fitzgeorge RB: The Effect of Oxygen-dependent Antimicrobial
Systems on Strains of Legionella Pneumophila of Difference Virulence. J
Hyg(Lond) 1986;97(l): 61-9
-
44. Steiner BM, Wong GH, Sutrave P, et al: Oxygen Toxicity in Treponema
Pallidum: Deoxyribonucleic Acid Single-stranded Breakage Induced by Low
Doses of Hydrogen Peroxide. Can J Microbiol 1984; 30(12): 1467-76
-
45. Brandi G, Sestili P, Pedrini MA, et al: The Effect of Temperature
or Anoxia on Escherichia Coli ICIling Induced by Hydrogen Peroxide. Mutat
Res 1987; 190(4): 23740
-
46. Norkus EP, Kuenzig W, Conney AH: Studies on the Mutagenic Activity
of Ascorbic Acid in Vitro and in Vivo. Mutat Res 1983; 117(l):183-9
-
47. Klebanoff SJ and Shepard CC: Toxic Effect of the Peroxidase-hydrogen
peroxide- halide Antimicrobial System on mycobacterium leprae. Infect Immun
1984; 44(2): 534-6
-
48. Miller SA, Bia FJ, Coleman DI, et al: Pulmonary Macrophage Function
During Experimental Cytomegalovirus Interstitial Pneumonia. Infect Immun
1985; 47(l): 211-6
-
49. Belotskii SM, Filiudova OB, Pashutin SB, et al: Chemiluminescence
of Human Neutrophils as Affected by Opportunistic Microbes. Zh Mikrobiol
Epidemiol Immunobiol 1986; Mar (3): 89-92
-
50. Moran AP and Upton ME: Effect of Medium Supplements, Illumination
and Superoxide Dismutase on the Production of Coccoid Forms of Campylobacter
Jejuni ATCC29428. J Appi Bacteriol 1987; 62(l): 43-51
-
51. Looney RJ and Steigbigel RT: Role of the Vi Antigen of Salmonella
typhi in Resistance to Host Defense In Vitro. J Lab Clin Med 1986; 108(5):
506-16
-
52. Wilson CB and Weaver WM: Comparative Susceptibility of Group
B Streptococci and Staphylococcus aurcus to Killing by Oxygen Metabolites.
J Infect Dis 1985; 152(2): 323-9
-
53. Tenovuo J, Makinen & Sievers G: Antibacterial Effect of Lactoperoxidase
and Myelopcroxidase Against Bacillus cereus.Antimicrob Agents Chemother
1985; 27(l): 96-101
-
54. Miyasaki K-T, Wilson ME, Genco RJ: Killing of Actinobacillus
actinomycetemcomitans by the Human Neutrophil Mycloperoxidase-hydrogen
peroxide-chloride System. Infect Immun 1986; 53(l): 161-5
-
55. Rotstein OD, Nasmith PE, Grinstein S: The Bacteroides By-product
Succinic Acid Inhibits Neutrophil Respiratory Burst by Reducing Intracellular
pH. Infect Immun 1987; 55(4):864-70
-
56. Archibald FS and Duong MN: Superoxide Dismutase and Oxygen Toxicity
Defenses in the Genus Neisseria. Infect Immun 1986; 51(2): 631-41
-
57. Howard DH: Studies on the Catalase of Histoplasma Capsulatum.
Infect Inimun 1983; 39(3): 1161-6
-
58. Sasada M, Kubo A, Nishimura T, et al: Candidacidal Activity of
Monocyte-derived Human Macrophages; Relationship between Candida Killing
and Oxygen Radical Generation by Human Macrophages. J Leukocytc Biol 1987;
41(4): 289
-
59. Schaffner A, Davis CE, Schaffner T, et al: In Vitro Susceptibility
of Fungi to lulling by Neutrophil Granulocytes Discriminates Between Primary
Pathogenicity and Opportunism. J Clin Invest 1986; 78(2): 511-24
-
60. Levitz SM and Diamond RD: Mechanisms of Resistance of Aspergillus
fumigatus Conidia to Killing by Neutrophils In Vitro. J Infect Dis 1985;
152(l): 33-42
-
61. Gaigiani J N: Inhibition of Different Phases of Coccidiodides
immitis by Human Neutrophils or Hydrogen Peroxide. J Infect Dis 1986: 153(2):
217-22
-
62. Pesanti EL: Pncumocystis Carinii: Oxygen Uptake, Antioxidant
Enzymes, and Susceptibility to Oxygen- mediated Damage. Infect Immun 1984;
44(l): 7-11
-
63. Brinkmann V, Kaufmann SH, Simon MM, et al: Role of Macrophages
in Malaria: 02 Metabolite Production and Phagocytosis by Spienic Macrophages
During Lethal Plasmodium berghci and Self- limiting Plasmodium yoeiii Infection
in Mice. Infect Inunun 1984; 44(3): 743-6
-
64. Murray HW: Cellular Resistance to Protozoal Infection. Annu Rev
Med 1986; 37: 61-9
-
65. Paget TA, Fry M, Lloyd D: Effects of Inhibitors on the Oxygen
kinetics of Nippostrongylus brasiliensis. Mol Biochem Parasitol 1987; 22(2-3):
125-33
-
66. Ferrante A, Hill NL, Abell TJ, et al: Role of Myeloperodase in
the Killing of Naegieria fowleri by Lymphokine-altered Human Neutrophils.
Infect Immun 1987; 55(5): 1047-50
-
67. Passwell JH, Shor R, Gazit E, et al: The Effects of Con A-induced
Lymphokines from the T-lymphocyte Subpopulations on Human Monocytc Leishmaniacial
Capacity and H202 Production. Immun 1986; 59(2): 245-50
-
68. Kazura JW, de-Brito P, Rabbege J et al: Role of Granulocyte Oxygen
Products in Damage of Schistosoma mansoni Eggs In Vitro. J Clin Invest
1985; 75(4): 1297-307
-
69. Rothermel CD, Rubin BY, Jaffe EA, et al: Oxygen-independent Inhibition
of Intracellular Chiamydia psittaci Growth by Human Monocytes and Intcrferon-gamma-activated
Macrophages. J Immunol 1986; 137(2): 689-92
-
70. owells RE: The Modes of Action of Some Anti-protozoal Drugs.
Parasitology 1985; 90(pt4): 689-703
-
71. Wirth JJ, Kierszenbaum F, Sonnenfeld G et a]: Enhancing Effects
of Ganima Interferon on Phagocytic CellAssociation with and Villing of
Trypanosoma cruzi. Infect Immun 1985; 49(l): 61-6
-
72. Ghadirian E, Somcrficid SD, Kongshavn PA: Susceptibility of Entamoeba
Histolytica to Oxidants. Infect Immun 1986; 51(l): 263-7
-
73. Murray HW, Scavuzzo D, Jacobs JI, et al: In Vitro and In Vivo
Activation of Human Mononuclear Phagocytes by Interferon-gamma. Studies
with Normal and AIDS Monocytes. J Immunol 1987; 138(8): 2457-62
-
74. Podopiekina LE, Shutova NA, Fyodorov YuV: Influence of Several
Chemical Reagents on Lymphocytic Choriomeningitis and Tacaribc Viruses.
Virologie 1986; 37(l): 43-8
-
75. Doroshow JH: Role of Hydrogen Peroxide and Hydroxyl Radical Formation
in the Filling of Ehrlich Tumor Cells by Anticancer Quinones. Proc Natl
Acad Sci USA 1986; 83(12):4514-8
-
76. Zaizen Y, Nak-agawara A, Ikeda K- Patterns of Destruction of
Mousc Neuroblastoma Cells by Extracellular Hydrogen Peroxide Formed by
6-hydroxydopamine and Ascorbate. J Cancer Res Clin Oncol 1986; 111(2):
93-7
-
77. Agrawal P and Harper MJ: Studies on Peroxidase-catalyzed Formation
of Progesterone. Steroids 1982; 40(5): 569-79
-
78. Heikk-iia R and Cohen G: Inhibition of Biogenic Amine Uptake
by Hydrogen Peroxide: A Mechanism for Toxic Effects of 6-Hydroxydopamine.
Science 1971; 172: 1257-58
-
79. Grisham MB, Perez VJ, Everse J: Neuromelanogenic and Cytotoxic
Properties of Canine Brainstem Peroxidase. J Ncurochem 1987; 48(3): 876-82
-
80. Hess ML, Manson NH, Lower RR: Leukocyte-genreated Hydrogen Peroxide
Depression of Cardiac Sarcoplasmic Reticulum Calcium Transport. Transplantation
1983; 36(l):117-9
-
81. Verhoeven AJ, Mommersteeg ME, Akkerman JW: Balanced Contribution
of Glycolyte and Adenylate Pool in Supply of Metabolic Energy in Mitochrondia.
-
82. Scott JA, Fischman AJ, Khaw BA, et al: Free Radical Mediated
Membrane Depolarization in Renal and Cardiac Cells. Biochim Biophys Acta
1987; 899(l): 76-82
-
83. Rubanyi GM and Vanhoutte PM: Oxygen-derived Free Radicals, Endothelium
and Responsiveness of Vascular Smooth Muscle. Am J Physiol 1986; 250(5
pt 2): H815-821
-
84. Silin PJ, Strulowitz JA, Wolin MS, et al: Absence of a Role for
Superoxide Anion, Hydrogen Peroxide and Hydroxyl Radical in Endothelium-mediated
Relaxation of Rabbit Aorta. Blood Vessels 1985; 22(2): 65-73
-
85. Wei EP, Christman CW, Kontos HA, et al: Effects of Oxygen Radicals
on Cerebral Arterioles. Am J Physiol 1985; 248(2 pt 2): H157-62 Platelets.
J Biol Chem 1985; 260(5): 2621-4
-
86. Kontos HA: Qxygen Radicals in Cerebral Vascular Injury. Circ
Res 1985; 57(4): 508-16
-
87. Burke TM and Wolin MS: Hydrogen Peroxde Elicits Pulmonary Artery
Relaxation and Guanylate Cyclasc Activation. Am J Physiol 1987; 252(4 Pt
2): H721-32
-
88. Farr CH: Conference Presentation. First International Conference
on Bio-Oxidativc Medicine. Dallas, Texas February 1989
-
89. Hofmann C, Crettaz M, Burns P, et al: Cellular Responses Elicited
by Insulin Mimickers in Cells Lacking Detectable Plasma Membrane Insulin
Receptors. J Cell Biochem 1985; 27(4): 401-14
-
90. Farr CH: Possible Therapeutic Value of Intravenous Hydrogen Peroxide.
Plzen.lek Sborn., Suppl. 56, 1988: 171-173
-
91. Farber CM, Liebes LF, Kanganis DN, et al: Human B Lymphocytes
Show Greater Susceptibility to H202 Toxicity than T Lymphocytes. J Immunol
1984; 132(5): 2543-6
-
92. Setty BN, Jurek E, Ganley C, et al: Effects of Hydrogen Peroxide
on Vascular Arachidonic Acid Metabolism. Prostaglandins Leukotrienes Med
1984; 14(2): 205-13
Click here to go back to the information
page